Stock listing
Hanover:19X Axsome Therapeutics, Inc. Aktie
German listing (Hanover) of Axsome Therapeutics, Inc. · home listing NASDAQ:AXSM
Follow Axsome Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:AXSM
$156.07 USD -0.24 (-0.2%)
Close on Oct 22, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:AXSM
- Day range
- $154.24 – $158.08 USDOct 22, 2026
- Volume
- 832,348 sharesOct 22, 2026
- Market cap
- $8.18B USDAt the close on Oct 22, 2026 · price × 52.38M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:AXSM · Home | $156.07 USD | -0.24 (-0.2%) | 832,348 | $156.13 | $158.08 | $154.24 | $156.31 | Close on Oct 22, 2026 |
| LSE:0HKF | $155.24 USD | -2.42 (-1.5%) | 91 | $159.40 | $159.88 | $154.28 | $157.66 | Close on Oct 22, 2026 |
| Frankfurt:19X | €140.85 EUR | +1.35 (+1.0%) | 6 | €136.65 | €140.85 | €136.65 | €139.50 | Close on Oct 22, 2026 |
| Stuttgart:19X | €138.35 EUR | -0.35 (-0.3%) | — | €137.40 | €139.35 | €137.05 | €138.70 | Close on Oct 22, 2026 |
Daily closes
Last 3 months, Jul 22, 2026 – Oct 22, 2026 · NASDAQ:AXSM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $156.07 | -0.24 | -0.2% | $156.13 | $158.08 | $154.24 | 832,348 | |
| $156.31 | -3.27 | -2.0% | $158.83 | $160.60 | $156.04 | 524,754 | |
| $159.58 | +3.77 | +2.4% | $157.65 | $164.79 | $157.38 | 653,287 | |
| $155.81 | -1.33 | -0.8% | $157.54 | $158.66 | $154.50 | 781,459 | |
| $157.14 | -4.65 | -2.9% | $160.43 | $160.43 | $156.09 | 873,075 | |
| $161.79 | -0.43 | -0.3% | $163.44 | $169.96 | $160.27 | 802,582 | |
| $162.22 | +5.90 | +3.8% | $156.44 | $164.00 | $155.18 | 893,237 | |
| $156.32 | -9.68 | -5.8% | $166.01 | $166.55 | $155.69 | 1,242,806 | |
| $166.00 | -2.35 | -1.4% | $169.50 | $170.80 | $165.02 | 645,598 | |
| $168.35 | -1.73 | -1.0% | $170.18 | $170.64 | $166.12 | 894,518 | |
| $170.08 | -2.89 | -1.7% | $170.09 | $172.28 | $166.21 | 1,073,755 | |
| $172.97 | -1.37 | -0.8% | $174.00 | $177.91 | $172.48 | 887,361 | |
| $174.34 | -2.74 | -1.5% | $176.52 | $176.52 | $169.30 | 1,367,800 | |
| $177.08 | -2.17 | -1.2% | $179.25 | $179.70 | $175.73 | 858,900 | |
| $179.25 | -2.82 | -1.5% | $182.55 | $182.55 | $175.46 | 981,400 | |
| $182.07 | -2.32 | -1.3% | $184.39 | $185.67 | $181.75 | 660,200 | |
| $184.39 | -1.75 | -0.9% | $186.51 | $188.00 | $184.00 | 1,033,900 | |
| $186.14 | -7.75 | -4.0% | $191.41 | $194.25 | $182.10 | 1,577,600 | |
| $193.89 | -1.20 | -0.6% | $194.98 | $198.96 | $193.11 | 707,400 | |
| $195.09 | -0.94 | -0.5% | $197.68 | $201.42 | $194.35 | 838,200 | |
| $196.03 | +2.58 | +1.3% | $193.02 | $197.11 | $190.72 | 386,100 | |
| $193.45 | -9.65 | -4.8% | $204.01 | $204.70 | $189.05 | 913,000 | |
| $203.10 | -2.39 | -1.2% | $205.68 | $207.01 | $202.52 | 299,800 | |
| $205.49 | -2.29 | -1.1% | $208.17 | $210.85 | $203.38 | 543,500 | |
| $207.78 | -6.50 | -3.0% | $212.05 | $213.27 | $206.92 | 869,300 | |
| $214.28 | +2.31 | +1.1% | $215.59 | $216.47 | $208.63 | 681,400 | |
| $211.97 | +7.90 | +3.9% | $202.95 | $214.64 | $201.94 | 644,900 | |
| $204.07 | -12.51 | -5.8% | $215.02 | $215.02 | $203.78 | 591,300 | |
| $216.58 | -4.17 | -1.9% | $221.93 | $223.29 | $216.00 | 718,800 | |
| $220.75 | +9.635 | +4.6% | $212.71 | $229.62 | $212.44 | 1,228,400 | |
| $211.12 | +0.485 | +0.2% | $210.63 | $211.65 | $208.01 | 526,400 | |
| $210.63 | +2.81 | +1.4% | $207.97 | $211.22 | $205.76 | 428,400 | |
| $207.82 | +1.14 | +0.6% | $205.00 | $210.86 | $202.00 | 385,800 | |
| $206.68 | -1.67 | -0.8% | $207.01 | $208.51 | $205.49 | 438,200 | |
| $208.35 | -1.57 | -0.7% | $209.32 | $210.59 | $206.60 | 558,800 | |
| $209.92 | +7.09 | +3.5% | $203.11 | $210.55 | $201.55 | 608,200 | |
| $202.83 | +4.31 | +2.2% | $199.71 | $205.94 | $199.71 | 656,300 | |
| $198.52 | -0.50 | -0.3% | $199.00 | $200.74 | $197.05 | 503,700 | |
| $199.02 | -7.25 | -3.5% | $205.70 | $205.70 | $199.00 | 441,200 | |
| $206.27 | -0.88 | -0.4% | $205.00 | $208.26 | $203.71 | 586,300 | |
| $207.15 | +1.67 | +0.8% | $204.48 | $210.68 | $203.70 | 378,400 | |
| $205.48 | +0.08 | 0.0% | $207.58 | $209.53 | $200.19 | 731,500 | |
| $205.40 | -2.37 | -1.1% | $207.00 | $208.09 | $205.09 | 293,200 | |
| $207.77 | -0.26 | -0.1% | $207.22 | $210.87 | $206.50 | 734,900 | |
| $208.03 | -10.17 | -4.7% | $216.50 | $217.85 | $206.26 | 620,900 | |
| $218.20 | +2.51 | +1.2% | $218.93 | $222.46 | $216.73 | 572,000 | |
| $215.69 | -0.58 | -0.3% | $215.93 | $220.01 | $214.39 | 506,300 | |
| $216.27 | +2.60 | +1.2% | $212.01 | $216.96 | $211.44 | 511,800 | |
| $213.67 | -0.01 | 0.0% | $211.00 | $216.30 | $208.95 | 476,300 | |
| $213.68 | -0.98 | -0.5% | $215.76 | $221.55 | $212.63 | 705,300 | |
| $214.66 | -1.11 | -0.5% | $216.80 | $218.75 | $213.15 | 1,240,600 | |
| $215.77 | -5.12 | -2.3% | $222.33 | $223.05 | $215.35 | 834,377 | |
| $220.89 | +8.15 | +3.8% | $215.88 | $223.40 | $210.00 | 1,398,625 | |
| $212.74 | +2.61 | +1.2% | $210.13 | $214.39 | $208.61 | 1,024,400 | |
| $210.13 | -2.72 | -1.3% | $212.73 | $216.56 | $209.98 | 397,100 | |
| $212.85 | +0.68 | +0.3% | $214.49 | $218.12 | $209.26 | 665,100 | |
| $212.17 | +1.13 | +0.5% | $212.81 | $214.89 | $210.13 | 473,500 | |
| $211.04 | -6.95 | -3.2% | $215.50 | $216.25 | $206.94 | 962,800 | |
| $217.99 | -16.65 | -7.1% | $234.46 | $235.10 | $217.64 | 782,100 | |
| $234.64 | +7.22 | +3.2% | $229.25 | $235.21 | $223.71 | 714,400 | |
| $227.42 | -6.78 | -2.9% | $233.96 | $235.91 | $227.00 | 523,000 | |
| $234.20 | -4.17 | -1.7% | $241.95 | $242.10 | $232.34 | 404,100 | |
| $238.37 | -2.63 | -1.1% | $240.43 | $245.50 | $237.08 | 773,100 | |
| $241.00 | -0.53 | -0.2% | $240.92 | $242.96 | $237.78 | 462,000 | |
| $241.53 | +1.91 | +0.8% | $239.00 | $244.60 | $237.00 | 500,400 | |
| $239.62 | +2.67 | +1.1% | $235.69 | $240.73 | $233.73 | 648,300 |
- Ticker
- Hanover:19X
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Hanover
- Currency
- EUR
What changed lately
Latest news release · Oct 7, 2026
Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
Latest earnings call · Aug 10, 2026
Axsome Therapeutics (NASDAQ:AXSM) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 10, 2026
Q2 2026 Earnings Presentation
Earnings · 46 slides
Calls
Upcoming
Axsome Therapeutics (NASDAQ:AXSM) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 8:00 AM ET
Register
Replays
Axsome Therapeutics (NASDAQ:AXSM) Q2 2026 Earnings Call
Mon, Aug 10, 2026 · 8:00 AM ET
Watch TranscriptAxsome Therapeutics (NASDAQ:AXSM) Q1 2026 Earnings Call
Mon, May 04, 2026 · 8:00 AM ET
Watch TranscriptAxsome Therapeutics (NASDAQ:AXSM) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
Oct 7, 2026
Closed $172.97 (-0.8%) on Oct 7, 2026
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
Sep 21, 2026
Closed $205.49 (-1.1%) on Sep 21, 2026
Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026
Sep 17, 2026
Closed $214.28 (+1.1%) on Sep 17, 2026
Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation
Aug 31, 2026
Closed $198.52 (-0.3%) on Aug 31, 2026
Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 10, 2026
Closed $220.89 (+3.8%) on Aug 10, 2026
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy
Jul 15, 2026
Closed $237.53 (+1.0%) on Jul 15, 2026
Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10
Jul 14, 2026
Closed $235.26 (+3.1%) on Jul 14, 2026
Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)
Jul 7, 2026
Closed $249.76 (+3.0%) on Jul 7, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 46 slides · Aug 10, 2026
Q1 2026 Earnings Presentation
Earnings · 49 slides · May 4, 2026
Q4 2025 Earnings Presentation
Earnings · 47 slides · Feb 23, 2026
Q3 2025 Earnings Presentation
Earnings · 46 slides · Nov 3, 2025
Axsome Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 227 in all · newest Oct 7, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 10, 2026
- Decks
- 44 decks · latest Aug 10, 2026
Where Axsome Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AXSM · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2AA7B | LS Exchange | Germany | EUR |
| Tradegate:19X | Tradegate | Germany | EUR |
| gettex:19X | gettex | Germany | EUR |
| BMV:AXSM | BMV | Mexico | MXN |
| LSE:0HKF | LSE | United Kingdom | USD |
| Lang & Schwarz:A2AA7B | Lang & Schwarz | Germany | EUR |
| Milan:1AXSM | Milan | Italy | EUR |
| Frankfurt:19X | Frankfurt | Germany | EUR |
| BIVA:AXSM | BIVA | Mexico | MXN |
| BOATS:AXSM | BOATS | United States | USD |
| BX Swiss:AXSM | BX Swiss | Switzerland | CHF |
| Stuttgart:19X | Stuttgart | Germany | EUR |
| Dusseldorf:19X | Dusseldorf | Germany | EUR |
| Hamburg:19X | Hamburg | Germany | EUR |
| Munich:19X | Munich | Germany | EUR |
| Hanover:19X · This page | Hanover | Germany | EUR |
| Xetra:19X | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Axsome Therapeutics, Inc.